La Merie

La Merie is a provider of information about biopharmaceutical R&D and competitive intelligence by Publishing, Consultancy and its Biotech Portal PipelineReview.com. La Merie produces, edits and publishes La Merie Daily, R&D Pipeline News, Competitor Analysis reports and full reports.

Results 21 - 40 of 79 go to 1st page

first

previous 1 2 3 4 next

last

Title	Date	Price
Elastase Inhibitors Competitor Analysis	May 2009	£180
Ras-Raf-MEK-ERK Inhibitors Competitor Analysis	May 2009	£315
Novel Mitotic Kinase Inhibitors Competitor Analysis	May 2009	£315
PARP Inhibitors Competitor Analysis	Apr 2009	£89
Sphingosine-1-Phosphate (S1P) Competitor Analysis	Apr 2009	£89
Hypoxia-Inducible Factor (HIF) Competitor Analysis	Apr 2009	£89
CD3 Antagonists Competitor Analysis	Mar 2009	£180
EpCAM Antagonists Competitor Analysis	Mar 2009	£89
p38 MAPK Inhibitors Competitor Analysis	Mar 2009	£180
Amyotrophic Lateral Sclerosis/ Lou Gehrig's disease Competitor Analysis	Mar 2009	£180
Attention-Deficit Hyperactivity Disorder (ADHD) Competitor Analysis	Mar 2009	£180
Interleukin-1 (IL-1) and IL-1 receptor (IL-1R) Antagonists Competitor Analysis	Feb 2009	£89
Interleukin-6 (IL-6) and Receptor (IL-6R) Antagonists Competitor Analysis	Feb 2009	£89
Wet Age-Related Macular Degeneration (AMD) Competitor Analysis	Feb 2009	£270
TNF Antagonists & Agonists Competitor Analysis	Feb 2009	£270
Protein Kinase C (PKC) Inhibitors Competitor Analysis	Jan 2009	£180
C5a-R Antagonists Competitor Analysis	Jan 2009	£110
Anti-Infective Peptides Competitor Analysis	Jan 2009	£270
PTH Receptor Agonists Competitor Analysis	Jan 2009	£135
CD20 Antibodies Competitor Analysis	Jan 2009	£180